In addition, Finak et al. also showed that EIF3C (P < 0.001, fold change = −9.750), EIF3E (P < 0.001, fold change = −42.681), EIF3F (P < 0.001, fold change = −47.085), and EIF3I (P < 0.001, fold change = −6.013) were decreased in several kinds of breast cancer compared to standard samples [31]. Here, EIF3I is linked to breast carcinoma.